Cogent Biosciences grants 22,000 stock options and 16,500 RSUs to six new employees
COGT•Cogent Biosciences granted six new employees options to purchase 22,000 common shares and 16,500 restricted stock units on October 26, 2026, under its 2020 Inducement Plan.
1. Equity awards
The options have 10-year terms, with 25% vesting on the first anniversary of the grant date and the remainder in equal monthly installments over the following 36 months. The restricted stock units vest in equal annual installments over four years. Vesting requires continued employment through each vesting date.
